Yelena Janjigian was Named as the Recipient of the Endowed Carroll and Milton Petrie Chair 2025
Yelena Janjigian/mskcc.org

Yelena Janjigian was Named as the Recipient of the Endowed Carroll and Milton Petrie Chair 2025

MSK recently hosted a reception to honor Dr. Yelena Janjigian, Chief of Gastrointestinal Oncology, as the new recipient of the esteemed Endowed Carroll and Milton Petrie Chair. This is one of MSK’s highest honors, recognizing her outstanding contributions to cancer research and care. The event brought together leaders, colleagues, and supporters—and sparked a wave of praise and reactions across social media.

Dr. Yelena Janjigian’s achievement at Memorial Sloan Kettering Cancer Center (MSK) drew congratulations across social media.

Wungki Park:

“Practice-changing contributions and a beautiful narrative of a career dedicated to advancing oncology.

Congrats to Yelena Janjigian Endowment Full circle. Her journey began with Stephen D. Nimer.”

Yan Leyfman:

“Congratulations Dr. Yelena Janjigian – an extraordinary leader whose vision, rigor, and unstoppable drive have transformed the landscape of GI oncology. A true powerhouse, she elevates everyone around her and has set a new standard for turning research into real-world results.

18 FDA approvals in 7 years is not just an achievement – it’s a testament to her ability to galvanize teams, innovate boldly, and push the field forward with purpose. Grateful for role models like Dr. Janjigian who inspire the next generation to dream bigger, work harder, and change lives.”

Erika Ruiz-Garcia:

“Congratulations Dr Yelena Janjigian, you and your team got 18 FDA approvals for gastrointestinal cancers in just 7 years !!!”

Yelena Janjigian

You Can Also Read:

Reception Honors Dr. Yelena Janjigian as the Recipient of the Endowed Carroll and Milton Petrie Chair 2025

Yelena Janjigian-OncoDaily